Related Experiment Video
Updated: Sep 5, 2025

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
Gorham-Stout disease, a diagnosis of exclusion
Ilir Ahmetgjekaj1, Erisa Kola2, Anusha Parisapogu3
1University Clinical Center, Clinic of Radiology, Pristina, Kosovo, Albania.
Insights
Gorham-Stout disease (GSD), or vanishing bone disease, presents diagnostic challenges due to its rarity. This case highlights the importance of thorough investigation, including advanced imaging and immunohistochemistry, for accurate GSD diagnosis.
Area of Science:
- Orthopedics
- Pathology
- Radiology
Background:
- Gorham-Stout disease (GSD), also known as vanishing bone disease, is a rare idiopathic condition.
- It is characterized by progressive bone loss and proliferation of vascular and lymphatic tissues.
- The pathogenesis of GSD is poorly understood, complicating diagnosis, which is often made by exclusion.
Abstract:
Gorham-Stout disease (GSD) also known as vanishing bone disease is an idiopathic and rare condition characterized by gross and progressive bone loss along with excessive growth of vascular and lymphatic tissue. Very little is known about the pathogenesis of GSD, which makes the diagnosis challenging and often diagnosed by elimination. We report a case of GSD in a 41-year-old male patient. He presented with bone pain and initial imaging showed widespread osteolytic lesions in the cervical and mid thoracic spine, ribs, sternum, clavicles, scapula, and humerus. Two percutaneous bone biopsies were performed, followed by an open spine biopsy of the lumber 2 spinous process for histological examination. Unfortunately, no diagnosis was reached. Although, he was treated symptomatically, he kept enduring pain and presented again after 7 months. His laboratory values were out of the normal range which prompted thorough investigations. New imaging and bone biopsy revealed multiple osteolytic lesions and vascular lesion with cavernous morphology respectively. GSD was diagnosed after ruling out a neoplastic process and confirming the cavernous morphology with immunohistochemical stain. He was treated symptomatically with immunomodulators, bisphosphonates, and supplements. Patient was counseled to see the specialist regularly. This case will help to increase familiarity and shed insights in the diagnosis of GSD.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Serum Laboratory Studies, Stool Test, Breath Test
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Other Disorders of Digestive System

